quantisnow
FeedTopReportsPricing
⌘K
Live feed
01:00:00·163d
PRRelease
Molecular Partners AG logo

Molecular Partners Presents New Data for DLL3 Targeting Radiotherapy MP0712 at TRP Summit Europe 2025, Highlighting Initial Human Images and Mechanism of Action

MOLN· Molecular Partners AG
Health Care
Original source

Companies

  • MOLN
    Molecular Partners AG
    Health Care

Recent analyst ratings

  • Jan 27UpdateH.C. Wainwright$13.00
  • Aug 30UpdateRBC Capital Mkts-
  • Aug 29UpdateSVB Leerink$8.00
  • May 25UpdateCredit Suisse-
  • Apr 27UpdateCredit Suisse-

Related

  • PR4d
    Molecular Partners presents three posters at AACR 2026, with new preclinical data for first Switch-DARPin T cell engager MP0632 and DLL3 Radio-DARPin MP0712
  • SEC9d
    SEC Form 6-K filed by Molecular Partners AG
  • PR9d
    Molecular Partners Announces all Board Proposals Approved, Clare Fisher Elected as New Board Member at Annual General Meeting
  • SEC24d
    SEC Form 6-K filed by Molecular Partners AG
  • PR31d
    Molecular Partners Publishes Invitation to Annual General Meeting 2026 and Proposes Clare Fisher for Election to its Board of Directors
  • PR36d
    Molecular Partners Presents New Preclinical Data Highlighting Radio-DARPins' Amenability to Multiple Isotopes
  • PR37d
    Molecular Partners to Hold Three Poster Presentations at AACR 2026
  • SEC41d
    SEC Form 6-K filed by Molecular Partners AG
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022